0001437749-17-019919.txt : 20171129
0001437749-17-019919.hdr.sgml : 20171129
20171129162442
ACCESSION NUMBER: 0001437749-17-019919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171127
FILED AS OF DATE: 20171129
DATE AS OF CHANGE: 20171129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Daniel L
CENTRAL INDEX KEY: 0001672300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36913
FILM NUMBER: 171228608
MAIL ADDRESS:
STREET 1: 2656 CROSSPARK ROAD, SUITE 100
CITY: CORALVILLE
STATE: IA
ZIP: 52241
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KEMPHARM, INC
CENTRAL INDEX KEY: 0001434647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205894398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 CROSSPARK ROAD, SUITE E126
CITY: CORALVILLE
STATE: IA
ZIP: 52241
BUSINESS PHONE: 319-665-2575
MAIL ADDRESS:
STREET 1: 2500 CROSSPARK ROAD, SUITE E126
CITY: CORALVILLE
STATE: IA
ZIP: 52241
FORMER COMPANY:
FORMER CONFORMED NAME: KEMPHARM INC
DATE OF NAME CHANGE: 20080507
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-11-27
0001434647
KEMPHARM, INC
KMPH
0001672300
Cohen Daniel L
C/O KEMPHARM, INC.
2500 CROSSPARK ROAD, SUITE E126
CORALVILLE
IA
52241
1
EVP, Govt. & Public Relations
Common Stock
2017-11-27
4
P
0
1145
3.70
A
26145
D
Common Stock
2017-11-27
4
P
0
1310
3.75
A
27455
D
Common Stock
2017-11-27
4
P
0
2990
3.80
A
30445
D
Common Stock
2017-11-27
4
P
0
2055
3.85
A
32500
D
Common Stock
2017-11-29
4
G
0
2500
0
D
30000
D
Common Stock
2017-11-29
4
G
0
1250
0
A
1250
I
By Daughter.
Common Stock
2017-11-29
4
G
0
1250
0
A
1250
I
By Daughter.
The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account.
The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account.
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Daniel L. Cohen
2017-11-29